|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Fair value adjustments of mortgage-related assets and liabilities | |||||
| Loss on debt extinguishment | |||||
| Inventory impairment | |||||
| Impairment on other investment | |||||
| Abandonment of lot option contracts | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Cash held in escrow | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Mortgage loans held for sale | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale of mortgage servicing rights | |||||
| Expenditures related to development of rental properties | |||||
| Proceeds from sale of rental properties | |||||
| Payments for business combinations | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Borrowings under revolving credit facility | |||||
| Payments on revolving credit facility | |||||
| Proceeds from issuance of senior notes due 2033 | |||||
| Total proceeds from issuance of senior notes due 2033 | |||||
| Extinguishment of senior notes due 2027 | |||||
| Total extinguishment of senior notes due 2027 | |||||
| Borrowing under construction loan agreements | |||||
| Payments on construction loan agreements | |||||
| Proceeds from issuance of insurance premium notes and other | |||||
| Principal payments on insurance premium notes and other | |||||
| Debt issuance costs | |||||
| Net proceeds (payments) for mortgage repurchase facilities | |||||
| Withholding of common stock upon settlement of stock-based compensation awards | |||||
| Repurchases of common stock under stock repurchase program | |||||
| Payments for excise tax on repurchases of common stock | |||||
| Dividend payments | |||||
| Other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Net decrease | |||||
| Cash and cash equivalents and Restricted cash, Beginning of period | |||||
| Cash and cash equivalents and Restricted cash, End of period | |||||
| Supplemental cash flow disclosure | |||||
| Cash paid for income taxes | |||||
| Cash and cash equivalents and Restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash (Note 7) | |||||
Loading...